Judith A. Shizuru

13.6k total citations · 1 hit paper
179 papers, 8.1k citations indexed

About

Judith A. Shizuru is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Judith A. Shizuru has authored 179 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Hematology, 83 papers in Immunology and 40 papers in Oncology. Recurrent topics in Judith A. Shizuru's work include Hematopoietic Stem Cell Transplantation (109 papers), Immune Cell Function and Interaction (49 papers) and T-cell and B-cell Immunology (43 papers). Judith A. Shizuru is often cited by papers focused on Hematopoietic Stem Cell Transplantation (109 papers), Immune Cell Function and Interaction (49 papers) and T-cell and B-cell Immunology (43 papers). Judith A. Shizuru collaborates with scholars based in United States, Germany and Italy. Judith A. Shizuru's co-authors include Irving L. Weissman, Robert S. Negrin, Samuel Strober, Robert Lowsky, Karl G. Blume, Sussan Dejbakhsh‐Jones, Laura Johnston, Richard T. Hoppe, Brenda M. Sandmaier and Rainer Storb and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Judith A. Shizuru

173 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes

2018 275 citations Jonathan T. Sockolosky, Eleonora Trotta et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judith A. Shizuru United States	46	3.7k	3.6k	2.1k	1.1k	1.1k	179	8.1k
Richard A. Nash United States	48	2.7k 0.7×	4.9k 1.3×	1.6k 0.7×	676 0.6×	833 0.7×	176	7.8k
Frederic I. Preffer United States	43	2.3k 0.6×	1.6k 0.4×	2.0k 0.9×	984 0.9×	2.0k 1.8×	112	7.0k
Gabriela Rondón United States	41	2.1k 0.6×	4.7k 1.3×	2.3k 1.1×	594 0.5×	850 0.8×	254	7.0k
David B. Miklos United States	37	2.6k 0.7×	2.1k 0.6×	2.2k 1.0×	308 0.3×	1.5k 1.3×	224	6.5k
Martin Körbling United States	35	1.6k 0.4×	3.7k 1.0×	1.7k 0.8×	930 0.8×	1.0k 0.9×	107	6.3k
Claudio G. Brunstein United States	44	3.1k 0.8×	5.9k 1.6×	2.3k 1.1×	626 0.5×	600 0.5×	247	8.0k
Αchilles Anagnostopoulos Greece	51	1.8k 0.5×	3.5k 1.0×	3.2k 1.5×	735 0.6×	2.1k 1.9×	287	8.9k
Hans‐Jochem Kolb Germany	39	1.8k 0.5×	3.2k 0.9×	1.7k 0.8×	314 0.3×	746 0.7×	175	5.9k
Jeffrey J. Molldrem United States	46	4.1k 1.1×	3.8k 1.0×	3.4k 1.6×	199 0.2×	1.6k 1.5×	163	8.5k
JH Kersey United States	42	2.8k 0.8×	4.5k 1.2×	1.9k 0.9×	294 0.3×	1.2k 1.1×	108	7.5k

Countries citing papers authored by Judith A. Shizuru

Since Specialization

Citations

This map shows the geographic impact of Judith A. Shizuru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith A. Shizuru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith A. Shizuru more than expected).

Fields of papers citing papers by Judith A. Shizuru

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith A. Shizuru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith A. Shizuru. The network helps show where Judith A. Shizuru may publish in the future.

Co-authorship network of co-authors of Judith A. Shizuru

This figure shows the co-authorship network connecting the top 25 collaborators of Judith A. Shizuru. A scholar is included among the top collaborators of Judith A. Shizuru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith A. Shizuru. Judith A. Shizuru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spinner, Michael A., R. Alejandro Sica, John Tamaresis, et al.. (2023). Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents. Blood. 141(22). 2727–2737. 10 indexed citations

Muffly, Lori, Catherine J. Lee, Ankur Varma, et al.. (2022). Preliminary Data from a Phase 1 Study of JSP191, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning Is Well-Tolerated, Facilitates Chimerism and Clearance of Minimal Residual Disease in Older Adults with MDS/AML Undergoing Allogeneic HCT. Transplantation and Cellular Therapy. 28(3). S476–S478. 2 indexed citations

Shizuru, Judith A., Lori Muffly, Parveen Shiraz, et al.. (2022). Belumosudil Combination Therapy in Refractory Chronic Graft-Versus-Host Disease. Blood. 140(Supplement 1). 4788–4789. 5 indexed citations

Liang, Emily C., Lori Muffly, Parveen Shiraz, et al.. (2021). Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation. Transplantation and Cellular Therapy. 27(5). 405.e1–405.e6. 5 indexed citations

Busque, Stéphan, John D. Scandling, Robert Lowsky, et al.. (2020). Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal. Science Translational Medicine. 12(528). 41 indexed citations

Pang, Wendy W., Agnieszka Czechowicz, Aaron C. Logan, et al.. (2019). Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice. Blood. 133(19). 2069–2078. 43 indexed citations

Shaw, Peter J., et al.. (2019). Conditioning Perspectives for Primary Immunodeficiency Stem Cell Transplants. Frontiers in Pediatrics. 7. 434–434. 21 indexed citations

Sockolosky, Jonathan T., Eleonora Trotta, Giulia Parisi, et al.. (2018). Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes. Science. 359(6379). 1037–1042. 275 indexed citations breakdown →

Scandling, John D., Stéphan Busque, Robert Lowsky, et al.. (2018). Macrochimerism and clinical transplant tolerance. Human Immunology. 79(5). 266–271. 24 indexed citations

10.

Spinner, Michael A., Lori Muffly, Sally Arai, et al.. (2017). Consolidative CD8+ Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell Transplantation. Blood. 130. 2003–2003. 1 indexed citations

11.

Filatenkov, Alexander, Jeanette Baker, Antonia M.S. Mueller, et al.. (2015). Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions. Clinical Cancer Research. 21(16). 3727–3739. 358 indexed citations

12.

Benjamin, Jonathan, Saurabh Chhabra, Holbrook E. Kohrt, et al.. (2014). Total Lymphoid Irradiation–Antithymocyte Globulin Conditioning and Allogeneic Transplantation for Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Biology of Blood and Marrow Transplantation. 20(6). 837–843. 16 indexed citations

13.

Laport, Ginna G., Kevin Sheehan, Jeanette Baker, et al.. (2011). Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 17(11). 1679–1687. 112 indexed citations

14.

Cao, Thai M., Laura C. Lazzeroni, Schickwann Tsai, et al.. (2009). Identification of a Major Susceptibility Locus for Lethal Graft-versus-Host Disease in MHC-Matched Mice. The Journal of Immunology. 183(1). 462–469. 2 indexed citations

15.

Filatenkov, Alexander, Antonia Müller, William W. Tseng, et al.. (2009). Ineffective Vaccination against Solid Tumors Can Be Enhanced by Hematopoietic Cell Transplantation. The Journal of Immunology. 183(11). 7196–7203. 12 indexed citations

16.

Rotta, Marcello, Barry E. Storer, Firoozeh Sahebi, et al.. (2008). Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting. Blood. 113(14). 3383–3391. 71 indexed citations

17.

Sorror, Mohamed L., Barry E. Storer, Brenda M. Sandmaier, et al.. (2008). Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning. Journal of Clinical Oncology. 26(30). 4912–4920. 182 indexed citations

18.

Maris, Michael B., Brenda M. Sandmaier, Barry E. Storer, et al.. (2006). Unrelated Donor Granulocyte Colony-Stimulating Factor–Mobilized Peripheral Blood Mononuclear Cell Transplantation after Nonmyeloablative Conditioning: The Effect of Postgrafting Mycophenolate Mofetil Dosing. Biology of Blood and Marrow Transplantation. 12(4). 454–465. 75 indexed citations

19.

Hegenbart, Ute, Dietger Niederwieser, Brenda M. Sandmaier, et al.. (2005). Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors. Journal of Clinical Oncology. 24(3). 444–453. 181 indexed citations

20.

Maloney, DG, Ted Gooley, Ute Hegenbart, et al.. (2001). NONMYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTS (HSCT) FROM HLA-MATCHED RELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: CLINICAL RESULTS OF A TBI-BASED CONDITIONING REGIMEN. Blood. 742–743. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact